PACB Valuation
Pacific Biosciences of California Inc
$
0.986
- Overview
- Forecast
- Valuation
PACB Relative Valuation
PACB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PACB is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for PACB's competitors is 1.41, providing a benchmark for relative valuation. Pacific Biosciences of California Inc Corp (PACB) exhibits a P/S ratio of 1.98, which is 40.50% above the industry average. Given its robust revenue growth of -4.27%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
MTLS
Materialise NV
5.190
USD
+0.39%
MUX
McEwen Mining Inc
7.620
USD
+1.33%
SIGA
SIGA Technologies Inc
6.140
USD
-0.97%
MREO
Mereo BioPharma Group PLC
2.235
USD
-2.83%
EQV
EQV Ventures Acquisition Corp
10.410
USD
+0.38%
ANNX
Annexon Inc
1.990
USD
-5.24%
AAM
AA Mission Acquisition Corp
10.350
USD
0.00%
CVRX
CVRx Inc
6.340
USD
-9.30%
HPP
Hudson Pacific Properties Inc
1.885
USD
-5.28%
CENT
Central Garden & Pet Co
36.400
USD
-1.14%
FAQ
Is Pacific Biosciences of California Inc (PACB) currently overvalued or undervalued?
Pacific Biosciences of California Inc (PACB) is now in the Fair zone, suggesting that its current forward PS ratio of 1.98 is considered Fairly compared with the five-year average of 16.13. The fair price of Pacific Biosciences of California Inc (PACB) is between 0.93 to 12.56 according to relative valuation methord.
What is Pacific Biosciences of California Inc (PACB) fair value?
How does PACB's valuation metrics compare to the industry average?
What is the current P/B ratio for Pacific Biosciences of California Inc (PACB) as of May 21 2025?
What is the current FCF Yield for Pacific Biosciences of California Inc (PACB) as of May 21 2025?
What is the current Forward P/E ratio for Pacific Biosciences of California Inc (PACB) as of May 21 2025?